Research study Program year 2023 Source: CMS Open Payments

A Phase III, Randomized, Open-Label, Controlled, Multi-Center Study to

Research payments

$14,228,234

895 payments

Through program year 2023, $14,228,234 in research payments was reported against A Phase III, Randomized, Open-Label, Controlled, Multi-Center Study to, across 895 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$806,285	82
2022	Research	$11,251,112	625
2021	Research	$2,170,836	188

Breakdown

Who paid Research payments · program years 2021–2023

GlaxoSmithKline, LLC. $14,228,234 895 payments

Who received the money Research payments · program years 2021–2023

Velocity Clinical Research INC Organisation paid for research $1,509,668 112 payments
New Orleans Center For Clinical Research Organisation paid for research $1,473,062 70 payments
Jean Brown Research INC Organisation paid for research $1,157,389 18 payments
Cognitive Clinical Trials LLC Organisation paid for research $1,053,919 51 payments
Clinical Neuroscience Organisation paid for research $931,634 55 payments
Fomat Medical Research INC Organisation paid for research $745,763 28 payments
Multicare Health Systems Organisation paid for research $713,789 15 payments
Lynn Health Science Institute Organisation paid for research $586,633 34 payments
Renstar Medical Research INC Organisation paid for research $494,330 16 payments
Suncoast Research Group LLC Organisation paid for research $489,905 24 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.